56 Biggest Movers From Yesterday

Gainers

• Top Image Systems Ltd. TISA shares climbed 55.43 percent to close at $0.83 on Monday after the company entered into a definitive agreement to be acquired by Kofax for $0.86 per share in cash.
• Maxwell Technologies Inc. MXWL shares rose 49.51 percent to close at $4.59 after Tesla Inc TSLA announced plans to acquire Maxwell Technologies for $4.75 per share.
• PHI, Inc. PHII shares gained 32 percent to close at $5.94.
• StoneMor Partners L.P. STON shares rose 31.52 percent to close at $3.38 after reporting secured bank waiver and $35 million financing facility.
• Horizon Global Corporation HZN gained 21.3 percent to close at $2.62.
• Napco Security Technologies, Inc. NSSC jumped 20.16 percent to close at $18.54 following Q2 earnings.
• The Ultimate Software Group, Inc. ULTI climbed 19.69 percent to close at $332.54 after the company agreed to be acquired by Hellman & Friedman for $331.50 per share in cash.
• Coffee Holding Co., Inc. JVA rose 18.34 percent to close at $7.29.
• Eyenovia, Inc. EYEN climbed 18.18 percent to close at $3.90 on Monday.
• Therapix Biosciences Ltd. TRPX shares rose 16.62 percent to close at $4.49.
• Constellation Pharmaceuticals, Inc. CNST surged 15.83 percent to close at $8.78 on Monday.
• INSYS Therapeutics, Inc. INSY rose 15.74 percent to close at $3.97.
• Aemetis Inc AMTX gained 15 percent to close at $1.15 after the company issued a notice of proposed award for a $5 million grant to the Aemetis Riverbank cellulosic ethanol biorefinery.
• Pyxus International, Inc. PYX climbed 14.96 percent to close at $17.06.
• Net 1 UEPS Technologies, Inc. UEPS climbed 14.88 percent to close at $3.32.
• BioLineRx Ltd. BLRX shares gained 14.52 percent to close at $0.7341 after the company received Orphan Drug Designation from the FDA for BL-8040 for the treatment of pancreatic cancer.
• The Alkaline Water Company Inc. WTER shares climbed 14.33 percent to close at $3.83 following a media report mentioning alkaline stated cannabis beverages will likely be one of the biggest sellers in retail outlets.
• Diebold Nixdorf, Incorporated DBD shares rose 14.22 percent to close at $4.98.
• Arvinas Holding Company, LLC ARVN shares surged 13.96 percent to close at $20.49.
• Avadel Pharmaceuticals plc AVDL jumped 13.26 percent to close at $3.16.
• Aphria Inc. APHA gained 12.68 percent to close at $10.84 after gaining 10.07 percent on Friday.
• Evolus, Inc. EOLS shares rose 11.78 percent to close at $20.50 after the company's Jeuveau injection received FDA approval.
• Cronos Group Inc. CRON gained 11.73 percent to close at $23.25.
• Neptune Wellness Solutions Inc. NEPT climbed 11.61 percent to close at $3.75. Neptune Wellness is expected to release Q3 results on February 13, 2019.
• Abeona Therapeutics Inc. ABEO shares climbed 11.6 percent to close at $7.60.
• MDJM Ltd. MDJH shares gained 11.28 percent to close at $5.13.
• Arcimoto, Inc. FUV shares surged 10.97 percent to close at $3.44.
• AgeX Therapeutics, Inc. AGE rose 10.92 percent to close at $4.47 on Monday.
• Orgenesis Inc. ORGS shares climbed 10.76 percent to close at $4.94.
• Covia Holdings Corporation CVIA jumped 10.56 percent to close at $5.34 on Monday.
• Wrap Technologies, Inc. WRTC gained 10.41 percent to close at $4.03.
• Diffusion Pharmaceuticals Inc. DFFN rose 10.22 percent to close at $2.48.
• BioXcel Therapeutics, Inc. BTAI jumped 10.04 percent to close at $5.92. BioXcel Therapeutics expanded indication for BXCL501 to treat symptoms associated with opioid drug withdrawal.
• Ellie Mae, Inc. ELLI climbed 9.89 percent to close at $83.99 following an unconfirmed media report the company may be exploring a sale.
• Babcock & Wilcox Enterprises, Inc. BW shares rose 9.06 percent to close at $0.6199 after the company successfully sold and turned over its second project out of four that it expected to turn over in the first and second quarters of 2019.
• Papa John's International, Inc. PZZA gained 8.98 percent to close at $41.97 despite lowering earnings expectations after hedge fund Starboard Equity made a $200 million investment in the company.
• Sonos, Inc. SONO shares gained 7.23 percent to close at $13.05.
• Clorox Co CLX gained 5.69 percent to close at $158.38 following upbeat quarterly earnings.
• ZK International Group Co Ltd ZKIN shares gained 4.32 percent to close at $1.69 after the company announced record FY18 revenue of $54.9 million.

Losers

• Check Cap Ltd CHEK shares declined 27.62 percent to close at $2.49 after the company announced an equity offering of 2.91 million shares and warrant units at $2.58 per unit for a total of $7.5 million.
• Medley Management Inc. MDLY shares dipped 23.08 percent to close at $3.80 on Monday after Nexpoint Advisors proposed merger transaction to Sierra Income Corporation and Medley Capital Corporation boards.
• OHR Pharmaceutical, Inc. OHRP fell 23.05 percent to close at $1.97.
• TMSR Holding Company Limited TMSR shares dropped 18.84 percent to close at $4.4800.
• Organogenesis Holdings Inc. ORGO shares fell 14.12 percent to close at $11.98.
• China SXT Pharmaceuticals, Inc. SXTC shares dropped 13.51 percent to close at $5.76.
• HyreCar Inc. HYRE shares fell 11.57 percent to close at $3.82.
• Fortress Biotech, Inc. FBIO dropped 9.72 percent to close at $2.23.
• Triton International Limited TRTN fell 9.47 percent to close at $32.20 after Bank of America downgraded the stock from Buy to Underperform and lowered the price target from $35 to $32.
• Digital Ally, Inc. DGLY fell 7.65 percent to close at $3.50.
• ClearOne, Inc. CLRO shares slipped 7.62 percent to close at $1.94 on Monday.
• Cool Holdings, Inc. AWSM dipped 7.37 percent to close at $2.64.
• Fate Therapeutics, Inc. FATE dropped 7.32 percent to close at $14.05.
• Adial Pharmaceuticals, Inc. ADIL shares slipped 6.1 percent to close at $6.46.
• Catalyst Pharmaceuticals, Inc. CPRX fell 5.58 percent to close at $2.37.
• Norbord Inc. OSB fell 5.11 percent to close at $28.58 after the company reported Q4 sales of $501 million versus the $532 million analyst estimate.
• AngloGold Ashanti Limited AU shares fell 4.83 percent to close at $13.61 despite the company guiding FY18 EPS above analyst estimates.